Genetic Testing
Bacterial Genome Sequencing De Novo Assembly and Annotation Illumina and ONT Hybrid
Bacterial de novo genome assembly and annotation for research; the catalog's Illumina/ONT hybrid label and current workflow require confirmation.
About this service
The title describes bacterial genome sequencing with de novo assembly and annotation. The platform names in the title are not independently verified as a current workflow; confirm the actual platforms, input and analysis for a project. Genome annotations can support research but do not diagnose infection or determine antibiotic susceptibility.
Service highlights
- Named analytical scope: de novo bacterial genome assembly and annotation.
- Potential use in bacterial-genomics research.
- Current platform and wet-lab workflow are unconfirmed.
Who may consider it
- Bacterial-genomics researchers.
- Microbiology laboratories with a defined isolate-genome project.
What to expect
Confirm current project availability and quote. Ask whether physical isolate, extracted DNA, prepared libraries or reads are accepted; confirm extraction, library preparation, sequencing platforms, assembly/annotation steps, QC and outputs. Agree handling and turnaround; no current SOP is supplied.
Scope and limitations
This listing is research sequencing/assembly/annotation, not clinical identification or antimicrobial susceptibility testing. Detected genes do not alone establish expression, resistance phenotype, infection causality or treatment choice.
Frequently asked questions
What does the named service do?
It describes bacterial genome sequencing, de novo assembly and annotation for a defined project.
Are Illumina and ONT currently used?
Those names appear in the catalog title, but current platform availability and hybrid workflow must be confirmed.
Does annotation establish resistance or treatment?
No. Gene annotations are not phenotypic susceptibility results or clinical treatment advice. Confirm availability and quote.